The payment of $55,000 was erroneously coded to ex gratia. The transaction was related to the construction of a Health Canada health center.
House of Commons photoWon his last election, in 2000, with 56% of the vote.
Questions On The Order Paper February 16th, 2000
The payment of $55,000 was erroneously coded to ex gratia. The transaction was related to the construction of a Health Canada health center.
Health Services February 16th, 2000
Mr. Speaker, it is obvious that the present state of health services is unacceptable. The status quo is unacceptable.
We have put certain ideas on the table with a view to improving the situation and I think that these ideas are valid both in Quebec and elsewhere.
I have invited my counterparts to a meeting in a few weeks' time and I hope that Mrs. Marois will be there.
Health February 14th, 2000
Mr. Speaker, lawyers for the Government of Canada are in court asking that every step possible be taken to make sure that money goes to claimants at the earliest possible moment.
Lawyers for the government oppose the payment of any fees to lawyers until claimants are paid, and will continue to do that. Lawyers for the government are in court asking that an administrator be appointed as soon as possible so we can start flowing the money to claimants that this settlement provides for.
Health December 16th, 1999
Mr. Speaker, the health protection branch operates entirely within the law. We operate motivated by compassion and concern for people who need treatments. We always operate so as to safeguard public safety and getting drugs on to the market that are effective.
Health December 16th, 1999
Mr. Speaker, Health Canada gets pharmaceutical products into the hands or the veins of patients as soon as possible, consistent with our being assured that they are safe and effective.
Recently we do that more quickly than in the past because we found ways within the law out of compassion for people who are suffering or in the late stages of disease. We do that because we want treatments in the hands of physicians and patients as soon as possible and consistent with public safety.
Standing Committee On Finance December 16th, 1999
moved:
That this House take note of the first report of the Standing Committee on Finance, presented to the House on Friday, December 10, 1999.
Questions On The Order Paper December 16th, 1999
(a) The food directorate will recive $7.7 million in 1999-2000 including $1.2 million for accommodation, communications, employee benefits, and other overhead expenses. As of October 3, 1999, the directorate had spent $3.2 million.
(b) By the end of year three of the funding, the food directorate plans to have staffed 52 positions. We are unable at this time to give actual position titles. It is anticipated that 25 will be staffed in year one, 10 in year two, and 17 in year three.
(c) The food directorate is scheduled to receive $7.7 million in year one, $9.2 million in year two, and $12.1 million in year three.
(d) There is currently one ongoing research project on a topic related to genetically modified foods with a planned expenditure in 1999-2000 of $166,389.
Question No. 38—
Health December 15th, 1999
Mr. Speaker, I understand that very subject is before the courts in litigation. Everybody will have ample opportunity to find out what the true facts are and then a court will judge.
The hon. member might do well to wait until the facts come out before jumping to the conclusions that he expressed so emphatically this afternoon.
Drug Approval December 15th, 1999
Yes, Mr. Speaker, and we are working with other governments for that purpose.
Let me tell the hon. member that we will approve these new pharmaceutical products as quickly as we can in keeping with the criteria of safety and efficacy. We will do that in every case.
In relation to the very drug that the member mentioned, he knows that we are working on that now. We are doing everything we can to bring that to market as soon as possible, consistent with public safety.
Drug Approval December 15th, 1999
Mr. Speaker, the Conservative Party cannot have it both ways: on the one hand, criticizing Health Canada because drug approvals take too long, and on the other, criticizing Health Canada because we innovate to get drug approvals through more quickly.
I can tell the hon. member that the bottom line for us is public safety and getting drugs to the patient as quickly as we can, consistent with public safety.